Exploratory analyses of biomarker using change of blood free amino-acid concentration related to JPH203(LAT1 inhibitor).
Not Applicable
- Conditions
- Solid tumors
- Registration Number
- JPRN-UMIN000016840
- Lead Sponsor
- School of Medicine, Kyorin University
- Brief Summary
The LAT1 inhibitor JPH203 showed promising activity against biliary tract cancer and high body mass index patients because of having sufficient gradients of LAT1-substarte plasma free amino acids, especially branched chain amino acids.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 17
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who refuse to supply the data.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Identification of biomarker related to efficacy of JPH203.
- Secondary Outcome Measures
Name Time Method To reveal difference in various tumors of blood free amino-acid concentration in patients with solid tumors.